Kamonkiat Wirunsawanya, MD
Basic profileKamonkiat Wirunsawanya is an Endocrinology/Metabolic physician affiliated with University of Hawaiʻi at Mānoa. OpenAlex indexes 21 publications with 397 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Esperion Therapeutics, Inc.Program year20251 payment$121
- Amgen Inc.Program year20251 payment$115
- Mannkind CorporationProgram year20251 payment$69
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
40.2%RANK Ligand Inhibitor38.9%Denosumab97%Prolia3%Part D + Part B≥29 patientsBisphosphonates0.9%Risedronate Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
26.8%GLP-1 receptor agonist10.9%Ozempic67%Mounjaro17%Rybelsus10%Trulicity6%Part D≥74 patientsInsulin Analog4.4%Lantus Solostar42%Novolog Flexpen28%Humalog Kwikpen U-10012%Tresiba Flextouch U-10010%Insulin Lispro Kwikpen U-1007%Part D<11 patients+ 9 more classes in this area
Hormonal (systemic)
20%l-Thyroxine14.9%Levothyroxine Sodium72%Synthroid28%Part D≥120 patientsThyroid Hormone Synthesis Inhibitor3.7%Methimazole100%Part D≥43 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Complication of Statin Therapy: Atorvastatin-Induced Agranulocytosis
Journal of Biology and Health Science
2026 - Concurrent Thyroid Storm From Postpartum Thyroiditis and Lymphocytic Hypophysitis: A Rare Case
Clinical Case Reports
2025 - SUN-121 Steroid cell tumor of the ovarian masquerading congenital adrenal hyperplasia
Journal of the Endocrine Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Cecilia Shikuma, MD
University of Hawaiʻi at Mānoa
Marian Melish, MD
University of Hawaiʻi at Mānoa
Ferdinand Hui, MD
University of Hawaiʻi at Mānoa
Todd Seto, MD
University of Hawaiʻi at Mānoa
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”